ALX Oncology Holdings Inc.
ALXO
$1.37
$0.053.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.60% | -31.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.01% | -26.23% | |||
| Operating Income | 4.01% | 26.23% | |||
| Income Before Tax | 14.66% | 15.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.66% | 15.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.66% | 15.62% | |||
| EBIT | 4.01% | 26.23% | |||
| EBITDA | 3.88% | 26.34% | |||
| EPS Basic | 14.87% | 15.77% | |||
| Normalized Basic EPS | 3.00% | 26.07% | |||
| EPS Diluted | 14.87% | 15.77% | |||
| Normalized Diluted EPS | 3.00% | 26.07% | |||
| Average Basic Shares Outstanding | 0.25% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||